| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Jiménez-Labaig, Pablo |
| dc.contributor.author | Aymerich, Clàudia |
| dc.contributor.author | Rullán, Antonio José |
| dc.contributor.author | Cacicedo, Jon |
| dc.contributor.author | Gonzalez-Torres, Miguel Angel |
| dc.contributor.author | Brana, Irene |
| dc.date.accessioned | 2024-06-13T07:56:56Z |
| dc.date.available | 2024-06-13T07:56:56Z |
| dc.date.issued | 2024-05-03 |
| dc.identifier.citation | Jimenez-Labaig P, Aymerich C, Braña I, Rullan A, Cacicedo J, González-Torres MÁ, et al. A comprehensive examination of mental health in patients with head and neck cancer: Systematic review and meta-analysis. JNCI Cancer Spectr. 2024 May 3;8(3):pkae031. |
| dc.identifier.issn | 2515-5091 |
| dc.identifier.uri | https://hdl.handle.net/11351/11580 |
| dc.description | Mental health; Head and neck cancer |
| dc.description.abstract | Background
Patients with head and neck cancer present particularly considerable levels of emotional distress. However, the actual rates of clinically relevant mental health symptoms and disorders among this population remain unknown.
Methods
A Preferred Reporting Items for Systematic Review and Meta-Analyses and Meta-analyses of Observational Studies in Epidemiology–compliant systematic review and quantitative random-effects meta-analysis was performed to determine suicide incidence and the prevalence of depression, anxiety, distress, posttraumatic stress, and insomnia in this population. MEDLINE, Web of Science, Cochrane Central Register, KCI Korean Journal database, SciELO, Russian Science Citation Index, and Ovid-PsycINFO databases were searched from database inception to August 1, 2023 (PROSPERO: CRD42023441432). Subgroup analyses and meta-regressions were performed to investigate the effect of clinical, therapeutical, and methodological factors.
Results
A total of 208 studies (n = 654 413; median age = 60.7 years; 25.5% women) were identified. Among the patients, 19.5% reported depressive symptoms (95% confidence interval [CI] = 17% to 21%), 17.8% anxiety symptoms (95% CI = 14% to 21%), 34.3% distress (95% CI = 29% to 39%), 17.7% posttraumatic symptoms (95% CI = 6% to 41%), and 43.8% insomnia symptoms (95% CI = 35% to 52%). Diagnostic criteria assessments revealed lower prevalence of disorders: 10.3% depression (95% CI = 7% to 13%), 5.6% anxiety (95% CI = 2% to 10%), 9.6% insomnia (95% CI = 1% to 40%), and 1% posttraumatic stress (95% CI = 0% to 84.5%). Suicide pooled incidence was 161.16 per 100 000 individuals per year (95% CI = 82 to 239). Meta-regressions found a statistically significant higher prevalence of anxiety in patients undergoing primary chemoradiation compared with surgery and increased distress in smokers and advanced tumor staging. European samples exhibited lower prevalence of distress.
Conclusions
Patients with head and neck cancer presented notable prevalence of mental health concerns in all domains. Suicide remains a highly relevant concern. The prevalence of criteria-meeting disorders is significantly lower than clinically relevant symptoms. Investigating the effectiveness of targeted assessments for disorders in highly symptomatic patients is essential. |
| dc.language.iso | eng |
| dc.publisher | Oxford University Press |
| dc.relation.ispartofseries | JNCI Cancer Spectrum;8(3) |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Suïcidi |
| dc.subject | Salut mental |
| dc.subject | Cap - Càncer |
| dc.subject | Coll - Càncer |
| dc.subject.mesh | Head and Neck Neoplasms |
| dc.subject.mesh | Suicide |
| dc.subject.mesh | Mental Health |
| dc.subject.mesh | Prevalence |
| dc.title | A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1093/jncics/pkae031 |
| dc.subject.decs | neoplasias de cabeza y cuello |
| dc.subject.decs | suicidio |
| dc.subject.decs | salud mental |
| dc.subject.decs | prevalencia |
| dc.relation.publishversion | https://doi.org/10.1093/jncics/pkae031 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Jimenez-Labaig P, Rullan A] Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK. The Institute of Cancer Research, National Institute of Health Research Biomedical Research Centre, London, UK. [Aymerich C] Psychiatry Department, Basurto University Hospital. Osakidetza, Basque Health Service, Bilbao, Spain. Biobizkaia Health Research Institute, OSI Bilbao-Basurto, Bilbao, Spain. Centro de Investigación en Red de Salud Mental (CIBERSAM), Madrid, Spain. [Braña I] Grup de Tumors Toràcics i Càncer de Cap i Coll, Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Cacicedo J] Radiotherapy Department, Cruces University Hospital, Barakaldo, Spain. Biobizkaia Health Research Institute, OSI Ezkerraldea Enkarterri Cruces, Barakaldo, Spain. Faculty of Medicine, University of the Basque Country, Leioa, Spain. [González-Torres MÁ] Psychiatry Department, Basurto University Hospital. Osakidetza, Basque Health Service, Bilbao, Spain. Biobizkaia Health Research Institute, OSI Bilbao-Basurto, Bilbao, Spain. Centro de Investigación en Red de Salud Mental (CIBERSAM), Madrid, Spain. Neuroscience Department, University of the Basque Country (UPV/EHU), Leioa, Spain |
| dc.identifier.pmid | 38702757 |
| dc.identifier.wos | 001238015400001 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |